BACKGROUND: Few studies have investigated the disease burden and genetic diversity of human rhinoviruses (HRVs) in developing countries. OBJECTIVES: To assess the burden of HRV in Amman, Jordan, and to characterise clinical differences between HRV groups. STUDY DESIGN: We prospectively studied children <5 years, hospitalised with respiratory symptoms and/or fever in Amman, Jordan. Viruses were identified by real-time reverse transcriptase polymerase chain reaction (RT-PCR). VP4/VP2 gene sequencing was performed on HRV-positive specimens. RESULTS: Of the 728 enrolled children, 266 (37%) tested positive for picornaviruses, 240 of which were HRV. Of the HRV-positive samples, 62 (26%) were of the recently identified group HRVC, 131 (55%) were HRVA and seven (3%) were HRVB. The HRVC strains clustered into at least 19 distinct genotypes. Compared with HRVA-infected children, children with HRVC were more likely to require supplemental oxygen (63% vs. 42%, p=0.007) and, when co-infections were excluded, were more likely to have wheezing (100% vs. 82%, p=0.016). CONCLUSIONS: There is a significant burden of HRV-associated hospitalisations in young children in Jordan. Infection with the recently identified group HRVC is associated with wheezing and more severe illness.
BACKGROUND: Few studies have investigated the disease burden and genetic diversity of human rhinoviruses (HRVs) in developing countries. OBJECTIVES: To assess the burden of HRV in Amman, Jordan, and to characterise clinical differences between HRV groups. STUDY DESIGN: We prospectively studied children <5 years, hospitalised with respiratory symptoms and/or fever in Amman, Jordan. Viruses were identified by real-time reverse transcriptase polymerase chain reaction (RT-PCR). VP4/VP2 gene sequencing was performed on HRV-positive specimens. RESULTS: Of the 728 enrolled children, 266 (37%) tested positive for picornaviruses, 240 of which were HRV. Of the HRV-positive samples, 62 (26%) were of the recently identified group HRVC, 131 (55%) were HRVA and seven (3%) were HRVB. The HRVC strains clustered into at least 19 distinct genotypes. Compared with HRVA-infectedchildren, children with HRVC were more likely to require supplemental oxygen (63% vs. 42%, p=0.007) and, when co-infections were excluded, were more likely to have wheezing (100% vs. 82%, p=0.016). CONCLUSIONS: There is a significant burden of HRV-associated hospitalisations in young children in Jordan. Infection with the recently identified group HRVC is associated with wheezing and more severe illness.
Authors: Martin Mehlmann; Aleta B Bonner; John V Williams; Daniela M Dankbar; Chad L Moore; Robert D Kuchta; Amy B Podsiad; John D Tamerius; Erica D Dawson; Kathy L Rowlen Journal: J Clin Microbiol Date: 2007-02-14 Impact factor: 5.948
Authors: E Kathryn Miller; Xiaoyan Lu; Dean D Erdman; Katherine A Poehling; Yuwei Zhu; Marie R Griffin; Tina V Hartert; Larry J Anderson; Geoffrey A Weinberg; Caroline B Hall; Marika K Iwane; Kathryn M Edwards Journal: J Infect Dis Date: 2007-02-02 Impact factor: 5.226
Authors: Chloe L McIntyre; E Carol McWilliam Leitch; Carita Savolainen-Kopra; Tapani Hovi; Peter Simmonds Journal: J Virol Date: 2010-07-28 Impact factor: 5.103
Authors: Desmond W Cox; Joelene Bizzintino; Giovanni Ferrari; Siew Kim Khoo; Guicheng Zhang; Siobhan Whelan; Wai Ming Lee; Yury A Bochkov; Gary C Geelhoed; Jack Goldblatt; James E Gern; Ingrid A Laing; Peter N Le Souëf Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: Jamie L Everman; Satria Sajuthi; Benjamin Saef; Cydney Rios; Ari M Stoner; Mari Numata; Donglei Hu; Celeste Eng; Sam Oh; Jose Rodriguez-Santana; Eszter K Vladar; Dennis R Voelker; Esteban G Burchard; Max A Seibold Journal: J Allergy Clin Immunol Date: 2019-03-29 Impact factor: 10.793
Authors: Yury A Bochkov; Kelly Watters; Shamaila Ashraf; Theodor F Griggs; Mark K Devries; Daniel J Jackson; Ann C Palmenberg; James E Gern Journal: Proc Natl Acad Sci U S A Date: 2015-04-06 Impact factor: 11.205
Authors: Kazuyuki Nakagome; Yury A Bochkov; Shamaila Ashraf; Rebecca A Brockman-Schneider; Michael D Evans; Thomas R Pasic; James E Gern Journal: J Allergy Clin Immunol Date: 2014-03-14 Impact factor: 10.793
Authors: E Kathryn Miller; Jodell Linder; David Kraft; Monika Johnson; Pengcheng Lu; Benjamin R Saville; John V Williams; Marie R Griffin; H Keipp Talbot Journal: J Allergy Clin Immunol Date: 2015-08-06 Impact factor: 10.793